Skip to content

Effects of whey protein isolate long term consumption in comparison with soy protein isolate on appetite and calorie intake? anthropometric and metabolic indices, inflammatory and oxidative stress factors in healthy overweight and obese men

Effects of whey protein isolate long term consumption in comparison with soy protein isolate on appetite and calorie intake? anthropometric and metabolic indices, inflammatory and oxidative stress factors in healthy overweight and obese men

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201109062365N3
Enrollment
52
Registered
2012-02-21
Start date
2012-04-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and Overweight. Obesity and other hyperalimentation

Interventions

Intervention 1: Intervention Whey Protein Group: Whey Protein Isolate ,90%, 60 grams per day 30 minutes before lunch for 12 weeks. Intervention 2: Intervention Soy Protein Group: Soy Protein Isolate ,
Prevention
Intervention Whey Protein Group: Whey Protein Isolate ,90%, 60 grams per day 30 minutes before lunch for 12 weeks
Intervention Soy Protein Group: Soy Protein Isolate ,90%, 60 grams per day 30 minutes before lunch for 12 weeks

Sponsors

Vice Chancellor for Research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria:Healthy interested men between ages 30 to 65;BMI=25 to 40kg/m2; No usage of cigarette or drugs or alcohol; No usage of antioxidants; no usage of decreasing blood pressure drugs, decreasing blood lipids or decreasing blood glucose drugs; No usage of antioxidants, gain or lose weight supplements; No lose weight diets; No intake of high doses of caffeine during the last 3 months; No record of diabetes, high blood pressure, acute heart diseases or thyroid/kidney/liver diseases, blood disorders,infarction or other clinical problems increasing oxidative stress like injuries or sever burnings; No allergy to cow milk or soy; No sever weight change during the last month, No usage of drugs affecting body weight ( Hormones or antidepression drugs), Exclusion Criteria: Altering the activity levels or diets in comparison with the ones before the study; Compliance less than 70%

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Body composition. Timepoint: Before and at the end of the first, second and the third month of the intervention. Method of measurement: Body composition analysis device.;Body weight. Timepoint: Before and after the intervention and every two weeks. Method of measurement: Scale.;Appetite. Timepoint: Before and after the intervention and weekly reports. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Blood pressure. Timepoint: Before and after the intervention and every two weeks. Method of measurement: Mercury Barometer.;Serum Lipids Profile. Timepoint: Before and after intervention. Method of measurement: Autoanalyzer.;MDA. Timepoint: Before and after the intervention. Method of measurement: Autoanalyzer.;HS CRP. Timepoint: Before and after the intervention. Method of measurement: Autoanalyzer.;Glucose. Timepoint: Before and after the intervention. Method of measurement: Autoanalyzer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Reza Vafa

Tehran University of Medical Sciences

mrvafa@tums.ac.ir+98 21 8877 9119

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 4, 2026